3020-OL:HK:HK- (HKD)

COMMON STOCK | Other |

Last Closing

USD 1289.5

Change

+11.00 (+0.86)%

Market Cap

N/A

Volume

195.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-01 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
1863:HK China Longevity Group Company ..

N/A

USD 1.17B
8355:HK I-CONTROL

-0.01 (-2.22%)

USD 0.39B
8343:HK HongGuang Lighting Holdings Co..

+0.01 (+1.89%)

USD 0.31B
0648:HK CHINA RENJ

N/A

USD 0.12B
0177-OL:HK JIANGSU EXPRESS

N/A

N/A
0240-OL:HK BUILD KING HOLD

-0.01 (-0.90%)

N/A
0243-OL:HK QPL INT'L

+0.02 (+7.18%)

N/A
0182-OL:HK CHINA WINDPOWER

N/A

N/A
0259-OL:HK YEEBO (INT'L H)

N/A

N/A
0187-OL:HK JINGCHENG MAC

N/A

N/A

ETFs Containing 3020-OL:HK

DXZ:CA Dynamic Active U.S. Mid-C.. 11.35 % 0.87 %

+0.02 (+1.29%)

CAD 0.04B
IHF iShares U.S. Healthcare P.. 11.32 % 0.43 %

+0.12 (+1.29%)

N/A
XSGI:LSE Xtrackers S&P Global Infr.. 6.95 % 0.00 %

+23.00 (+1.29%)

USD 0.37B
XGID:LSE Xtrackers S&P Global Infr.. 6.95 % 0.00 %

+0.51 (+1.29%)

N/A
DX2E:F Xtrackers - S&P Global In.. 6.95 % 0.00 %

+0.73 (+1.29%)

N/A
DX2E:XETRA Xtrackers - S&P Global In.. 6.95 % 0.00 %

+0.19 (+1.29%)

USD 0.21B
TETF 6.19 % 0.64 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 5.31 % 0.75 %

+0.02 (+1.29%)

CAD 0.10B
FHI-B:CA CI Health Care Giants Cov.. 5.31 % 0.00 %

-0.25 (1.29%)

CAD 0.05B
MID American Century Mid Cap .. 4.56 % 0.00 %

+1.14 (+1.29%)

USD 0.08B
LCG Sterling Capital Focus Eq.. 4.37 % 0.00 %

+0.42 (+1.29%)

USD 0.03B
IAI iShares U.S. Broker-Deale.. 4.32 % 0.42 %

+2.27 (+1.29%)

N/A
CBUF:XETRA iShares MSCI World Health.. 3.14 % 0.00 %

-0.09 (1.29%)

N/A
HDIV 2.83 % 0.00 %

N/A

N/A
DSTL Distillate US Fundamental.. 1.86 % 0.00 %

+0.51 (+1.29%)

USD 1.92B
RYH 1.72 % 0.40 %

N/A

N/A
HONR 1.20 % 0.65 %

N/A

N/A
SMD 0.45 % 0.10 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

-0.10 (1.29%)

USD 0.08B
JKH iShares Morningstar Mid-C.. 0.00 % 0.30 %

N/A

N/A
RYF 0.00 % 0.40 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

+0.51 (+1.29%)

N/A
WBIF WBI BullBear Value 3000 E.. 0.00 % 1.05 %

+0.17 (+1.29%)

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
FSWD:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.38 (+1.29%)

N/A
IFSW:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.04 (+1.29%)

N/A
IBCZ:F iShares IV Public Limited.. 0.00 % 0.00 %

+0.15 (+1.29%)

N/A
IS07:F iShares IV Public Limited.. 0.00 % 0.00 %

+0.15 (+1.29%)

N/A
IS07:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.07 (+1.29%)

N/A
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

+0.93 (+1.29%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.11% 35% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.11% 35% F 38% F
Trailing 12 Months  
Capital Gain 6.44% 53% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.44% 48% F 54% F
Trailing 5 Years  
Capital Gain 143.30% 79% B- 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 143.30% 79% B- 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 16.52% 78% C+ 76% C+
Dividend Return 16.52% 75% C 74% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.34% 77% C+ 76% C+
Risk Adjusted Return 85.42% 97% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike